Rising to the challenge of CovID-19: Advice for pulmonary and critical care and an agenda for research

American Journal of Respiratory and Critical Care Medicine

Volumn 201, Issue 9, 2020, Pages 1019-1022

  Niederman, Michael S ^a,b   Richeldi, Luca ^c   Chotirmall, Sanjay H ^d   Bai, Chunxue ^e,f  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b WEILL CORNELL MEDICAL CENTER   (United States)

^c FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^d NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^e ZHONGSHAN HOSPITAL OF FUDAN UNIVERSITY   (China)

^f Shanghai Research Institute   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; CYTOKINE RECEPTOR ANTAGONIST; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; JANUS KINASE INHIBITOR; LOPINAVIR PLUS RITONAVIR; REMDESIVIR; STEROID; TOCILIZUMAB;

ADULT RESPIRATORY DISTRESS SYNDROME; AEROSOL; ANTIBIOTIC THERAPY; ARTIFICIAL VENTILATION; CORONAVIRUS DISEASE 2019; CRITICALLY ILL PATIENT; EMOTIONAL STRESS; EVIDENCE BASED PRACTICE; EXTRACORPOREAL OXYGENATION; HEALTH CARE PERSONNEL; HOSPITAL BED CAPACITY; HUMAN; INCUBATION TIME; INFECTION PREVENTION; INTENSIVE CARE; MORTALITY RATE; NONHUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; PULMONOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESEARCH PRIORITY; REVIEW; SAFETY; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; VIRUS PNEUMONIA; VIRUS TRANSMISSION; WELLBEING; BETACORONAVIRUS; CORONAVIRUS INFECTION; INTENSIVE CARE UNIT; MEDICAL RESEARCH; MORTALITY; PANDEMIC; RISK FACTOR;

BETACORONAVIRUS; BIOMEDICAL RESEARCH; CORONAVIRUS INFECTIONS; CRITICAL CARE; HUMANS; INTENSIVE CARE UNITS; PANDEMICS; PNEUMONIA, VIRAL; PULMONARY MEDICINE; RISK FACTORS;

EID: 85083212823     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/RCCM.202003-0741ED     Document Type: Review

References (16)

1. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese center for disease control and prevention. JAMA [online ahead of print] 24 Feb 2020; DOI: 10.1001/jama.2020.2648.
2. Xie J, Tong Z, Guan X, Du B, Qiu H, Slutsky AS. Critical care crisis and some recommendations during the COVID-19 epidemic in China. Intensive Care Med [online ahead of print] 2 Mar 2020; DOI: 10.1007/s00134-020-05979-7.
3. Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med [online ahead of print] 13 Mar 2020; DOI: 10.1001/jamainternmed.2020.0994.
4. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet [online ahead of print] 11 Mar 2020; DOI: 10.1016/S0140-6736(20)30566-3.
5. Chen J. Pathogenicity and transmissibility of 2019-nCoV-A quick overview and comparison with other emerging viruses. Microbes Infect 2020;22:69–71.
6. Lauer SA, Grantz KH, Bi Q, Jones FK, Zheng Q, Meredith HR, et al. The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application. Ann Intern Med [online ahead of print] 10 Mar 2020; DOI: 10.7326/M20-0504.
7. van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN, et al. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N Engl J Med [online ahead of print] 17 Mar 2020; DOI: 10.1056/NEJMc2004973.
8. Bai L, Yang D, Wan X, Tong L, Zhu X, Zhong Z, et al. Chinese experts’ consensus on the internet of things-aided diagnosis and treatment of coronavirus disease 2019 (COVID-19). Clinical eHealth 2020;3: 7–15.
9. Grasselli G, Pesenti A, Cecconi M. Critical care utilization for the COVID-19 outbreak in Lombardy, Italy: early experience and forecast during an emergency response. JAMA [online ahead of print] 13 Mar 2020; DOI: 10.1001/jama.2020.4031.
10. Parodi SM, Liu VX. From containment to mitigation of COVID-19 in the US. JAMA [online ahead of print] 13 Mar 2020; DOI: 10.1001/jama.2020.3882.
11. Murthy S, Gomersall CD, Fowler RA. Care for critically ill patients with COVID-19. JAMA [online ahead of print] 11 Mar 2020; DOI: 10.1001/jama.2020.3633.
12. Fan E, Del Sorbo L, Goligher EC, Hodgson CL, Munshi L, Walkey AJ, et al.; American Thoracic Society, European Society of Intensive Care Medicine, and Society of Critical Care Medicine. An official American Thoracic Society/European Society of Intensive Care Medicine/Society of Critical Care Medicine Clinical Practice Guideline: mechanical ventilation in adult patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 2017;195: 1253–1263.
13. Shi H, Han X, Jiang N, Cao Y, Alwalid O, Gu J, et al. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis [online ahead of print] 24 Feb 2020; DOI: 10.1016/S1473-3099(20)30086-4.
14. Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, et al. A trial of lopinavir-ritonavir in adults hospitalized with severe covid-19. N Engl J Med [online ahead of print] 18 Mar 2020; DOI: 10.1056/NEJMoa2001282.
15. Gautret P, Lagiera J-C, Parola P, Hoang VT, Meddeb L, Mailhea M, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents [online ahead of print] 20 Mar 2020; DOI: 10.1016/j.ijantimicag.2020.105949.
16. Hollander JE, Carr BG. Virtually perfect? Telemedicine for covid-19. N Engl J Med [online ahead of print] 11 Mar 2020; DOI: 10.1056/NEJMp2003539.